Bonaire, Sint Eustatius and Saba vs Kazakhstan: Prevalence of hepatitis B surface antigen (HBsAg), 2026 methodology
Bonaire, Sint Eustatius and Saba
0.2%
in 2024
Kazakhstan
0.2%
in 2024
Bonaire, Sint Eustatius and Saba rank
98th
Kazakhstan rank
98th
Prevalence of hepatitis B surface antigen (HBsAg), 2026 methodology over time
- Bonaire, Sint Eustatius and Saba
- Kazakhstan
How they compare
Bonaire, Sint Eustatius and Saba currently reports 0.2% against 0.2% in Kazakhstan, a difference of 0.0%.
The two have swapped places 1 time across 10 shared years of data; in 2015 it was Bonaire, Sint Eustatius and Saba ahead.
Bonaire, Sint Eustatius and Saba ranks 98th and Kazakhstan ranks 98th of 246 countries.
Bonaire, Sint Eustatius and Saba has averaged higher in every one of the 2 decades both report.
Head to head by decade
| Decade | Bonaire, Sint Eustatius and Saba | Kazakhstan | Difference | Ahead |
|---|---|---|---|---|
| 2010s | 0.3% | 0.2% | 0.1% | Bonaire, Sint Eustatius and Saba |
| 2020s | 0.2% | 0.2% | 0.0% | — |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher prevalence of hepatitis b surface antigen (hbsag), 2026 methodology, Bonaire, Sint Eustatius and Saba or Kazakhstan?
- Bonaire, Sint Eustatius and Saba, at 0.2% against 0.2% in Kazakhstan as of 2024.
- What is the difference in prevalence of hepatitis b surface antigen (hbsag), 2026 methodology between Bonaire, Sint Eustatius and Saba and Kazakhstan?
- 0.0%, with Bonaire, Sint Eustatius and Saba ahead.
- How many years of comparable data are there for Bonaire, Sint Eustatius and Saba and Kazakhstan?
- 10 years are reported by both, from 2015 to 2024.
- How do Bonaire, Sint Eustatius and Saba and Kazakhstan rank globally for prevalence of hepatitis b surface antigen (hbsag), 2026 methodology?
- Bonaire, Sint Eustatius and Saba ranks 98th and Kazakhstan ranks 98th of 246 countries.
- Where does this data come from?
- United Nations Statistics Division, SDG Global Database, published as Prevalence of hepatitis B surface antigen (HBsAg), 2026 methodology (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.